Monitoring clinical trials in infectious diseases
- PMID: 35005713
- PMCID: PMC8740779
- DOI: 10.46439/allergy.2.019
Monitoring clinical trials in infectious diseases
Similar articles
-
Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.Clin Trials. 2011 Dec;8(6):727-35. doi: 10.1177/1740774511425181. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024105
-
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.Pharmacotherapy. 2009 Nov;29(11):1275-9. doi: 10.1592/phco.29.11.1275. Pharmacotherapy. 2009. PMID: 19873687 Review.
-
Mapping time use in clinical trials for vaccines against emerging infectious diseases.Clin Trials. 2021 Jun;18(3):286-294. doi: 10.1177/1740774520977283. Epub 2021 Mar 2. Clin Trials. 2021. PMID: 33653146
-
American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.Am J Transplant. 2006 Feb;6(2):262-74. doi: 10.1111/j.1600-6143.2005.01207.x. Am J Transplant. 2006. PMID: 16426310
-
Probiotics for the Management of Infectious Diseases: Reviewing the State of the Art.Front Microbiol. 2022 Apr 28;13:877142. doi: 10.3389/fmicb.2022.877142. eCollection 2022. Front Microbiol. 2022. PMID: 35572661 Free PMC article. Review.
References
-
- World Health Organization Declares COVID-19 a “pandemic”: Here is what that means, March 11, 2020: https://time.com/5791661/who-coronavirus-pandemic-declaration/ accessed March 20, 2021
-
- Rome BN, Avorn J. Drug Evaluation during the Covid-19 Pandemic. NEJM. 2020. April 14. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources